As of April 16, 2025, Recursion Pharmaceuticals (RXRX) has a market cap of $2.27 billion USD. According to our data, Recursion Pharmaceuticals is ranked No.3797 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.27 B |
-12.60%
|
Dec 31, 2024 | $2.59 B |
-31.44%
|
Dec 29, 2023 | $3.78 B |
27.89%
|
Dec 30, 2022 | $2.96 B |
-54.99%
|
Dec 31, 2021 | $6.57 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Schrödinger
SDGR
|
$1.87 B |
0.235 B
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Exscientia
EXAI
|
$0.63 B |
0.000 M
|
![]() UK
|
![]() AbCellera
ABCL
|
$0.72 B |
-0.000 M
|
![]() Canada
|
![]() Atomera
ATOM
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() BioXcel Therapeutics
BTAI
|
$9.95 M |
0.000 M
|
![]() USA
|
![]() Recursion Pharmaceuticals
RXRX
|
$2.27 B |
39.023 M
|
![]() USA
|
![]() UiPath
PATH
|
$5.83 B |
0.819 B
|
![]() USA
|
Market Cap | = | RXRX Stock Price | * | RXRX Shares Outstanding |
= | $5.64 | * | 0.40 B | |
= | $2.27 B |